A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

ClinicalTrials.gov ID: NCT07223463

Public ClinicalTrials.gov record NCT07223463. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 29, 2026, 5:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to learn if a tailored intervention can help make it easier for adolescents and young adults with cancer to take their medications. The main questions the researchers are trying to answer are: * Does the tailored intervention increase adherence? * Does the tailored intervention improve quality of life? * Does the tailored intervention reduce health care utilization? The researchers will compare the tailored intervention to a uniform standard of care intervention (an intervention designed to be similar to what is currently happening in clinical care) to see if the tailored intervention works to improve adherence. Participants will: * Use an electronic pill bottle or box to store their medication * Participate in intervention sessions * Complete surveys before the intervention, after the intervention, and 6-months later

Study identification

NCT ID: NCT07223463
Recruitment status: Not yet recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Enrollment: 160 participants

Conditions and interventions

Conditions

Interventions

Feedback Program (Uniform Standard of Care) Behavioral
Tailored Program Behavioral

Behavioral

Eligibility (public fields only)

Age range: 15 Years to 24 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2026
Primary completion: Jan 30, 2030
Completion: Aug 30, 2030
Last update posted: Jun 23, 2026

2026 – 2030

United States locations

U.S. sites: 4
U.S. states: 4
U.S. cities: 4

Facility	City	State	ZIP	Site status
The University of Kansas Medical Center	Kansas City	Kansas	66160	—
Columbia University Irving Medical Center	New York	New York	1003230702	—
Cincinnati Children's Hospital Medical Center	Cincinnati	Ohio	45229	—
Seattle Children's Hospital	Seattle	Washington	98105	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07223463, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 23, 2026 · Synced Jul 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07223463 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →